Zenych A, Fournier L, Chauvierre C. Nanomedicine progress in thrombolytic therapy. Biomaterials. 2020;258:120297.

Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.

Lutsey PL, Zakai NA. Epidemiology and prevention of venous thromboembolism. Nat Rev Cardiol. 2023;20(4):248–62.

Article  PubMed  Google Scholar 

Correa-Paz C, da Silva-Candal A, Polo E, Parcq J, Vivien D, Maysinger D, et al. New approaches in nanomedicine for ischemic stroke. Pharmaceutics. 2021;13(5).

Wang Y, Pisapati AV, Zhang XF, Cheng X. Recent developments in nanomaterial-based shear-sensitive drug delivery systems. Adv Healthc Mater. 2021;10(13):e2002196.

Ma H, Jiang Z, Xu J, Liu J, Guo ZN. Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke. Drug Deliv. 2021;28(1):357-71.

Zhu J, Wang J, Li Y. Recent advances in magnetic nanocarriers for tumor treatment. Biomed Pharmacother. 2023;159.

Article  CAS  PubMed  Google Scholar 

Song D, Li C, Zhu M, Chi S, Liu Z. Tracking hepatic ischemia-reperfusion injury in real time with a reversible NIR-IIb fluorescent redox probe. Angew Chem Int Ed Engl. 2022;61(44).

Article  CAS  PubMed  Google Scholar 

Cabrera D, Eizadi Sharifabad M, Ranjbar JA, Telling ND, Harper AGS. Clot-targeted magnetic hyperthermia permeabilizes blood clots to make them more susceptible to thrombolysis. J Thromb Haemost. 2022;20(11):2556–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu W, Yin N, Yang Y, Xuan C, Liu X, Liu W, et al. Rescuing ischemic stroke by biomimetic nanovesicles through accelerated thrombolysis and sequential ischemia-reperfusion protection. Acta Biomater. 2022;140:625–40.

Article  CAS  PubMed  Google Scholar 

Shen M, Wang Y, Hu F, Lv L, Chen K, Xing G. Thrombolytic agents: nanocarriers in targeted release. Molecules (Basel, Switzerland). 2021;26(22):6776.

Article  CAS  PubMed  Google Scholar 

Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med. 2008;359(9):938–49.

Article  CAS  PubMed  Google Scholar 

De Maeseneer MG, Kakkos SK, Aherne T, Baekgaard N, Black S, Blomgren L, et al. Editor's choice - European Society for Vascular Surgery (ESVS) 2022 clinical practice guidelines on the management of chronic venous disease of the lower limbs. Eur J Vasc Endovasc Surg. 2022;63(2):184–267.

Article  PubMed  Google Scholar 

Manz XD, Bogaard HJ, Aman J. Regulation of VWF (von Willebrand factor) in inflammatory thrombosis. Arterioscler Thromb Vasc Biol. 2022;42(11):1307–20.

Article  CAS  PubMed  Google Scholar 

Bettiol A, Alibaz-Oner F, Direskeneli H, Hatemi G, Saadoun D, Seyahi E, et al. Vascular Behcet syndrome: from pathogenesis to treatment. Nat Rev Rheumatol. 2023;19(2):111–26.

Article  CAS  PubMed  Google Scholar 

Zhou S, Zhao W, Hu J, Mao C, Zhou M. Application of nanotechnology in thrombus therapy. Adv Healthc Mater. 2023;12(7).

Article  PubMed  Google Scholar 

Dou H, Kotini A, Liu W, Fidler T, Endo-Umeda K, Sun X, et al. Oxidized phospholipids promote netosis and arterial thrombosis in LNK(SH2B3) deficiency. Circulation. 2021;144(24):1940–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alkarithi G, Duval C, Shi Y, Macrae FL, Ariens RAS. Thrombus structural composition in cardiovascular disease. Arterioscler Thromb Vasc Biol. 2021;41(9):2370–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Adrover JM, Pellico J, Fernández-Barahona I, Martín-Salamanca S, Ruiz-Cabello J, Hidalgo A, et al. Thrombo-tag, an in vivo formed nanotracer for the detection of thrombi in mice by fast pre-targeted molecular imaging. Nanoscale. 2020;12(45):22978–87.

Article  CAS  PubMed  Google Scholar 

Klaeske K, Meyer AL, Saeed D, Eifert S, Jawad K, Sieg F, et al. Decreased platelet specific receptor expression of P-selectin and GPIIb/IIIa predict future non-surgical bleeding in patients after left ventricular assist device implantation. Int J Mol Sci. 2022;23(18).

Bachelet L, Bertholon I, Lavigne D, Vassy R, Jandrot-Perrus M, Chaubet F, et al. Affinity of low molecular weight fucoidan for p-selectin triggers its binding to activated human platelets. Biochem Biophys Acta. 2009;1790(2):141–6.

Article  CAS  PubMed  Google Scholar 

Nayak L, Sweet DR, Thomas A, Lapping SD, Kalikasingh K, Madera A, et al. A targetable pathway in neutrophils mitigates both arterial and venous thrombosis. Sci Transl Med. 2022;14(660):eabj7465.

Hajtuch J, Iwicka E, Szczoczarz A, Flis D, Megiel E, Cieciorski P, et al. The pharmacological effects of silver nanoparticles functionalized with eptifibatide on platelets and endothelial cells. Int J Nanomedicine. 2022;17:4383–400.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yin R, Zhou L, Gao N, Lin L, Sun H, Chen D, et al. Unveiling the disaccharide-branched glycosaminoglycan and anticoagulant potential of its derivatives. Biomacromol. 2021;22(3):1244–55.

Article  CAS  Google Scholar 

Zhou XH, Cheng ZP, Lu M, Lin WY, Luo LL, Ming ZY, et al. Adiponectin receptor agonist adiporon modulates human and mouse platelet function. Acta Pharmacol Sin. 2023;44(2):356–66.

Article  CAS  PubMed  Google Scholar 

Souri M, Yokoyama C, Osaki T, Ichinose A. Antibodies against noncatalytic b subunit of factor XIII inhibit activation of factor XIII and fibrin crosslinking. Thromb Haemost. 2023;123(9):841–54.

Article  PubMed  Google Scholar 

Pasternack R, Buchold C, Jahnig R, Pelzer C, Sommer M, Heil A, et al. Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a). J Thromb Haemost. 2020;18(1):191–200.

Article  CAS  PubMed  Google Scholar 

Zhang N, Ru B, Hu J, Xu L, Wan Q, Liu W, et al. Recent advances of creka peptide-based nanoplatforms in biomedical applications. J Nanobiotechnology. 2023;21(1):77.

Arjmand S, Pardakhty A, Forootanfar H, Khazaeli P. A road to bring Brij52 back to attention: shear stress sensitive Brij52 niosomal carriers for targeted drug delivery to obstructed blood vessels. Med Hypotheses. 2018;121:137–41.

Article  CAS  PubMed  Google Scholar 

Behera SS, Pramanik K, Nayak MK. Recent advancement in the treatment of cardiovascular diseases: conventional therapy to nanotechnology. Curr Pharm Des. 2015;21(30):4479–97.

Article  CAS  PubMed  Google Scholar 

Mohri H, Ohkubo T. How vitronectin binds to activated glycoprotein IIb-IIIa complex and its function in platelet aggregation. Am J Clin Pathol. 1991;96(5):605–9.

Article  CAS  PubMed  Google Scholar 

Huang J, Li X, Shi X, Zhu M, Wang J, Huang S, et al. Platelet integrin alphaIIbbeta3: signal transduction, regulation, and its therapeutic targeting. J Hematol Oncol. 2019;12(1):26.

Article  PubMed  PubMed Central  Google Scholar 

Xiong B, Jha V, Min JK, Cho J. Protein disulfide isomerase in cardiovascular disease. Exp Mol Med. 2020;52(3):390–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Juenet M, Aid-Launais R, Li B, Berger A, Aerts J, Ollivier V, et al. Thrombolytic therapy based on fucoidan-functionalized polymer nanoparticles targeting p-selectin. Biomaterials. 2018;156:204–16.

Article  CAS  PubMed  Google Scholar 

Setiadi H, Yago T, Liu Z, McEver RP. Endothelial signaling by neutrophil-released oncostatin m enhances P-selectin-dependent inflammation and thrombosis. Blood Adv. 2019;3(2):168–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Libby P. The changing landscape of atherosclerosis. Nature. 2021;592(7855):524–33.

Article  CAS  PubMed  Google Scholar 

Wei Z, Xin G, Wang H, Zheng H, Ji C, Gu J, et al. The diosgenin prodrug nanoparticles with pH-responsive as a drug delivery system uniquely prevents thrombosis without increased bleeding risk. Nanomedicine. 2018;14(3):673–84.

Article  CAS  PubMed  Google Scholar 

Mitchell JL, Little G, Bye AP, Gaspar RS, Unsworth AJ, Kriek N, et al. Platelet factor XIII-a regulates platelet function and promotes clot retraction and stability. Res Pract Thromb Haemost. 2023;7(5).

Article  PubMed  PubMed Central  Google Scholar 

Poon C, Gallo J, Joo J, Chang T, Bañobre-López M, Chung EJ. Hybrid, metal oxide-peptide amphiphile micelles for molecular magnetic resonance imaging of atherosclerosis. J Nanobiotechnology. 2018;16(1):92.

Peters D, Kastantin M, Kotamraju VR, Karmali PP, Gujraty K, Tirrell M, et al. Targeting atherosclerosis by using modular, multifunctional micelles. Proc Natl Acad Sci USA. 2009;106(24):9815–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Davie EW, Kulman JD. An overview of the structure and function of thrombin. Semin Thromb Hemost. 2006;32(Suppl 1):3–15.

Article  CAS  PubMed  Google Scholar 

Gunawan ST, Kempe K, Bonnard T, Cui J, Alt K, Law LS, et al. Multifunctional thrombin-activatable polymer capsules for specific targeting to activated platelets. Adv Mater (Deerfield Beach, Fla). 2015;27(35):5153–7.

Lin KY, Lo JH, Consul N, Kwong GA, Bhatia SN. Self-titrating anticoagulant nanocomplexes that restore homeostatic regulation of the coagulation cascade. ACS Nano. 2014;8(9):8776–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, Vemuri C, Palekar RU, Gaut JP, Goette M, Hu L, et al. Antithrombin nanoparticles improve kidney reperfusion and protect kidney function after ischemia-reperfusion injury. Am J Physiol Renal Physiol. 2015;308(7):F765–73.

Article  CAS